CYTOPOINT is now approved for the treatment of allergic dermatitis! Learn more
This site is intended for U.S. animal healthcare professionals
CYTOPOINT® offers long-lasting relief that removes the burden of daily dosing treatments1
DUBLIN, male, age 9 years, Newfoundland
Veterinarian: Dr Dan Hebert, Duxbury Animal Hospital, Duxbury, MA
Dublin’s owner does important work that makes daily treatment schedules impractical
Presentation and history
Dublin had been suffering for years with rashes on his stomach and ear infections. His constant discomfort led him to gnaw at his skin compulsively. Dublin’s owner assumed his issues stemmed from environmental allergies.
Dublin had always been a happy and intuitive dog who enjoyed his therapy visits with patients with Alzheimer’s disease in nursing homes. Dublin’s owner was frustrated that Dublin continued to suffer with his skin disease. She felt burdened by an ineffective, constantly changing treatment plan that interfered with Dublin’s meaningful work. Her exhausting schedule also made it extremely challenging for her to administer daily treatments.
“There was never a solution or something proactive to do. It was always reactive.” — SherryAnn Quindley, 9/7/16
Dublin’s skin is fully healed, and he has regained his happy disposition
Dr Hebert diagnosed the cause of Dublin’s persistent itch as atopic dermatitis, and gave him an injection of CYTOPOINT. He also prescribed CONVENIA® (cefovecin sodium) for the pyoderma, and a long-acting treatment for the otitis.
CYTOPOINT treatment result
Dublin made a full recovery and continues to do well. He sleeps through the night and is back to his happy, active lifestyle and beach trips. Dublin and his owner can now enjoy life, free from the distraction of canine atopic dermatitis and the inconvenience of daily medication administration.
“I watch him now, and he is back to being that fun-loving dog…I know that he’s going to be okay. And that peace of mind is literally priceless.” — SherryAnn Quindley, 9/7/16
Indication:CYTOPOINT aids in the reduction of clinical signs associated with atopic dermatitis in dogs.
CONVENIA Indication:CONVENIA is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphlyococcus intermedius and Streptococcus canis.
IMPORTANT SAFETY INFORMATION:People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CONVENIA. Do not use in dogs or cats with a history of allergic reactions to penicillins or cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased appetite/anorexia and lethargy. For more information, please see the full Prescribing Information.
Reference: 1. Data on file, CYTOPOINT Case Studies, Zoetis Inc.
Testimonials represent individual experience only, and the experiences and opinions may be unique to the patient and the speaker. Individual results may vary considering the unique characteristics of the patient.
This site is intended for U.S. Animal Healthcare Professionals. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.
The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.